Patent · US Expired

3-Substituted oxindole β3 agonists

US7205407B2 · kind B2 · utility

0Cited by

9References

6Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Jolie Anne Bastian · Indianapolis, US
Gerd Ruehter · Hamburg, DE
Daniel Jon Sall · Greenwood, US
Theo Schotten · Winsen (Luhe), DE

Key dates

Filing date	Nov 12, 2002
Grant date	Apr 17, 2007
Priority date	—
Expiry date	Mar 14, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a β3 adrenergic receptor agonist of Formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.